DEGENERATIVE DISC DISEASE TREATMENT MARKET ANALYSIS

Degenerative disc disease is a spinal condition caused by the breakdown of intervertebral discs. The symptoms observed for degenerative disc disease are tingling or numbness in legs or difficulty walking. This disease is diagnosed with physical examination, through X-rays or magnetic resonance imaging (MRI). The degenerative disc disease is most commonly seen in geriatric population and have caused low back pain and neck pain in adults. The common cases of back pain among patients occurs at the lower side of the back.

The global degenerative disc disease treatment market is estimated to be valued at US$ 2,235.1 million in 2022 and is expected to exhibit a CAGR of 9.2% during the forecast period (2022-2030).

Figure 1. Global Degenerative Disc Disease Treatment Market Share (%), by Product Type, 2022

To learn more about this report, request a free sample copy

Global Degenerative Disc Disease Treatment Market - Drivers

Increasing adoption of inorganic strategies such as product launch by key market players is expected to drive the global degenerative disc disease treatment market growth over the forecast period. For instance, in December 2020, NuVasive, Inc., a medical device company, announced that they launched C360 cervical spine portfolio. They had also announced commercial launch of new Anterior Cervical Plating system which is designed to minimize common postoperative complications such as dysphagia, malalignment and adjacent level ossification.

Figure 2. Global Degenerative Disc Disease Treatment Market Value (US$ Million), by Region, 2022

To learn more about this report, request a free sample copy

Global Degenerative Disc Disease Treatment Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.

COVID-19 can affect the economy in three main ways: by directly affecting production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, U.A.E., Egypt, and others, are facing problems with regards to the transportation of drugs from one place to another.

However, the COVID-19 pandemic had a negative impact on the global degenerative disc disease treatment market. For instance, in April 2020, according to the data published in National Center for Biotechnology Information, the COVID-19 pandemic affects the spinal care by delaying of surgical care in infected patients, reallocation of hospital resources (such as nursing staff and ICU beds) to the care of patients with the coronavirus as well as cancellation of elective surgeries and office visits in order to reduce the chances of disease spread. The combination of both of these has led to sudden and drastic changes in the daily routine of not only spine surgeons but also of other professionals involved in spine care, such as pain management and rehabilitation physicians, physical therapists and occupational therapists.

Global Degenerative Disc Disease Treatment Market: Key Developments

Increasing adoption of inorganic strategies such as product launch by key market players is expected to drive global degenerative disc disease treatment market. For instance, in October 2020, 4WEB Medical, an orthopedic implant device company, announced that they had launched spine implant portfolio, the stand-alone anterior lumbar spine truss system, an integrated interface for three fixation screws while maintaining the open architecture and fundamental benefits inherent to the truss design.

Global Degenerative Disc Disease Treatment Market: Restraint

Increasing number of product recalls by regulatory authorities such as the U.S. Food and Drug Administration is expected to hinder the market growth over the forecast period. For instance, in January 2021, the U.S. Food and Drug Administration recalled cervalign anterior cervical plate system-cervalign, intended for anterior cervical fixation of degenerative disc disease, which was manufactured by RTI Surgical, a surgical implant company. The product was recalled because the locking mechanism had been observed to disassociate intraoperatively and postoperatively resulting in replacement.

Global Degenerative Disc Disease Treatment Market - Key Players

Major players operating in the global degenerative disc disease treatment market include Medtronic, Globus Medical, Johnson & Johnson Services, Inc., Zimmer Biomet, B. Braun SE, RTI Surgical, Cousin Biotech, ulrich medical USA, Fresenius Kabi AG, Abbott, Spine Wave, Inc., RIVANNA MEDICAL, ZAVATION, Orthofix US LLC., Spinal Simplicity, Nexus Spine, NuVasive, Inc., Aurora Spine, Inc., 4WEB Medical.